Breast and Cervical Cancer Prevention and Treatment Act of 1999
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
97pct
442d open
vs 5,680 other HR bills in the 106th — cohort avg 56d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2000 · year_end · Health Issues
Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. The Breast and Cervical Cancer Treatment Act H.R. 1070, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” S. 662, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” Breast Cancer and Environmental Research Act of 1999 H.R. 3433 / S. 2287, Breast Cancer and Environmental Research Act of 1999, Section 3, Amendments to Subpart 12 of part C of title IV of the Public Health Service Act that add research centers regarding environmental factors related to breast cancer. Medicare Cancer Clinical Trial Coverage Act of 1999 H.R. 1388, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing “a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program” S. 784, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program Genetic Nondiscrimination Legislation H.R. 306, Genetic Information Nondiscrimination in Health Insurance Act of 1999, Section 2, Amendments to Employee Retirement Income Security Act of 1974; Subsection 714 Prohibition of health insurance discrimination on the basis of genetic information and Section 3 Amendments to the Public Health Service Act, Subsection 9814, Prohibition of discrimination by group health plans on the basis of genetic information. H.R. 2457 / S. 1322, Genetic Nondiscrimination in Health Insurance and Employment Act of 1999, Title I, all provisions relating to the prohibition of health insurance discrimination on the basis of predictive genetic information; Title II, all provisions relating to the prohibition of employment discrimination on the basis of predictive genetic information. Patients’ Bill of Rights: H.R. 2723, The Bipartisan Consensus Managed Care Act of 1999, Title I, Subtitle A – Grievance and Appeals, improving managed care through internal and external appeals processes; Subtitle B – Access to Care, Sec. 114 – providing for access to specialty care, Sec. 117 – providing for continuity of care, and Sec. 119 – providing for individuals participating in approved clinical trials. S. 6, Patients’ Bill of Rights Act of 1999, Subtitle A, all provisions relating to access to care specifically, Section 106, coverage for individuals participating in approved clinical trials and Section 105, continuity of care provisions. Also Subtitle F, Section 152, “standards relating to benefits for certain breast cancer treatment” and Subtitle D, grievance and appeals procedures.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), President of the U.S., SENATE, Vice President of the U.S.
2000 · year_end · Health Issues
PL-105-115-Food and Drug Modernization Act of 1997. (Improvements to FDA regulatory process for medical devices. Oversight activities conducted to monitor progress of FDA in imeplementing legislative provisions.) S. 2743-Voluntary Error Reduction and Improvement and Patient Safety Act S. 2038-Medical Error ReductionAct of 2000 S. 2738-Patient Safety and Errors Reduction Act H.R. 3672- Medication Error Prevention Act (Bills intended to reduce medical errors and to enhance research on medical errors as it may directly or indirectly relate to medical tehcnology.) S. 110-Breast and Cervical Cancer Treatment Act H.R.1070/H.R. 4376-Breast and Cervical Cancer Prevention and Treatment Act S. 662-Bill to Amend Title XIX of the Social Security Act to Provide Medical Assistance for Certain Women Screened and Found to Have Breast or Cervical Cancer Under a Federally Funded Screening Program (Bills intended to provide breast and cervical cancer treatment to women in Medicaid with a specific provision requiring HPV warnings on condom labels.) H.R. 2498-Cardiac Arrest Survival Act of 1999 (Expanded access to medical devices used to treat cardiac arrest.)
Client expense: $2,040,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE